Oversight Committee

* Co-Chairs

 

Charles Gore

World Hepatitis Alliance

 

Paul Kuehnert

Robert Wood Johnson Foundation

 

Wangsheng Li*

ZeShan Foundation


Lillian Lou

The John C. Martin Foundation


Nicole Smith

CAPT, USPHS, retired

Mike van der Ven*

Pivotal Ventures

Stefan Wiktor

WHO, retired


 

Charles Gore

World Hepatitis Alliance

 

Mr. Charles Gore (London, Great Britain) was diagnosed with hepatitis C in 1995 and cirrhosis in 1998. In 2000 he set up The Hepatitis C Trust together with 3 friends who also had hepatitis C. In 2002 he did pegylated interferon and ribavirin treatment and successfully eradicated the virus.He has continued to run the Trust, working extensively with Government Departments and the National Health Service (NHS) in the UK, championing the patient perspective. He was closely involved in the creation of the European Liver Patients Association and was elected its first President in 2004. In 2007 he organised a meeting of hepatitis patient organisations from around the world to agree on co-ordinated global action. From this emerged the decision to hold an annual World Hepatitis Day and to create a new NGO, the World Hepatitis Alliance, of which Charles is the President. As a result of advocacy by the Alliance and its members WHO adopted successive viral hepatitis resolutions in 2010 and 2014, making World Hepatitis Day an official day and mandating the creation of a global strategy to tackle viral hepatitis. 

Charles sits on a number of national and international advisory bodies including various WHO hepatitis guidelines development groups and the WHO Director-General’s Strategic and Technical Advisory Committee for Viral Hepatitis. 

 

Paul Kuehnert

Robert Wood Johnson Foundation

 

Dr. Paul Kuehnert (Princeton NJ, USA) is Assistant Vice President – Program, for the Robert Wood Johnson Foundation where he provides leadership and management direction for the Foundation’s work related to leadership and transforming health and health care systems. 

As an executive leader for the past 25 years, Kuehnert has led both governmental and community-based organizations in order to help people lead healthier lives. In the late 1980s he was a founder and later CEO of Community Response, Inc., one of the Chicago-area’s largest housing, nutrition and social service providers for people living with HIV/AIDS. He moved to Maine in 1999 and served in the state health department, leading the development of a regional public health system and becoming deputy director of the department in 2005. Most recently Paul was the county health officer and executive director for health in Kane County, Illinois, a metro-Chicago county of 515,000 where he initiated and led "Making Kane County Fit for Kids," a public-private partnership to reverse the epidemic of childhood obesity. 

Kuehnert is a pediatric nurse practitioner and holds the Doctor of Nursing Practice in executive leadership as well as the Master of Science in public health nursing degrees from the University of Illinois at Chicago. He was named a Robert Wood Johnson Foundation Executive Nurse Fellow in 2004 and inducted into the American Academy of Nursing in 2015.

 

Wangsheng Li

ZeShan Foundation

 

Mr. Wangsheng Li (Hong Kong SAR, China) is president of ZeShan Foundation (Hong Kong) and a Senior Fellow of the Synergos Institute (New York City). A private family foundation based in Hong Kong, ZeShan Foundation has made it a strategic focus for its Health Programs portfolio to foster strategic partnerships in the effective control and eventual elimination of viral hepatitis, with a particular emphasis on hepatitis B and an integrated approach to the prevention of mother to child transmission of HBV, HIV and syphilis. 

This commitment is reflected in the Pledge of Action jointly announced by Ms. Laura Chen, ZeShan’s late executive chair and President Bill Clinton in 2008: “We commit to eliminating the transmission of hepatitis B and to reducing discrimination of those injected with the virus." 

In a unique partnership with USCDC and WHO, ZeShan Foundation has recently embarked on an ambitious effort initiating the creation of a dedicated fund for combating viral hepatitis in the context of the WHO Global Hepatitis Strategy.

 

Lillian Lou

The John C. Martin Foundation

 

Dr. Lillian Lou (California USA) has worked at The John C. Martin Foundation since its inception and formation in 2014. Prior to joining the Foundation, a private non-profit organization in the USA, Lillian has over 20 years of work experience in the pharmaceutical industry. She directed discovery biology research and clinical studies in several disease areas including hepatitis C and hepatitis B, respectively. 

Previously at Gilead Sciences, as a member of the Access Program, she was responsible for leading the medical science activities in HIV/AIDS and viral hepatitis for the developing countries. Lillian was trained as a research scientist and holds a PhD degree in biochemistry from University of California, Los Angeles. She was a National Institute of Health (NIH) post-doctoral research fellow at Stanford University in California. She was further trained in certification programs offered by University of California Santa Cruz and received certificates in clinical research and management, and regulatory affairs.

 

Nicole Smith

CAPT, USPHS, retired

 

Nicole M. Smith, PhD, MPH MPP (CAPT, USPHS, retired), was previously the Associate Director for Policy & Communication for the Division of Viral Hepatitis at the U.S. Centers for Disease Control and Prevention (CDC), where she provided strategic information and advice to Division senior and professional staff regarding planning; legislative and policy analysis; program development, implementation, and evaluation; performance monitoring and evaluation; partner engagement; and, issues management. 

Dr. Smith has experience working on domestic and global health issues in a variety of subject areas, including viral hepatitis; childhood, adolescent, and adult immunization; seasonal, avian, and pandemic influenza preparedness and response; global health security; primary care; emergency preparedness and response; and, environmental health hazards. During her more than 25-year career, Dr. Smith held a range of positions with the U.S. Public Health Service, including assignments with the World Health Organization. 

In addition to serving on the EndHEP2030 Oversight Committee, Dr. Smith is a member of the Board of the American Liver Foundation. 

Dr. Smith received her BA from Brown University and her PhD, MPH, and MPP from the University of California at Berkeley; and is now pursuing an MBA in Sustainable Systems from the Presidio Graduate School. She also received applied epidemiology training through CDC’s Epidemic Intelligence Service program.  

 

 

Mike van der Ven

Pivotal Ventures

 

Mr. Mike van der Ven (Seattle, WA USA) joined Pivotal Ventures in June 2016. He serves as the primary owner and point of accountability for Pivotal finances, operational programs and projects. His two major areas of focus include organizational strategy and annual planning with a primary focus on efficiency and financial impact. Other focus areas include budget management, investments, key performance indicators (KPIs), IT and facilities management. 

Mike joined Pivotal from Fred Hutch in Seattle where he was Director of Finance and Operations for the HIV Vaccine Trials Network. He oversaw all aspects of operations supporting a global network of 40 clinical trials sites and 2000 scientific collaborators working toward the development of a HIV Vaccine. Prior to his time at Fred Hutch, Mike worked in a dual role with the Clinton Health Access Initiative (CHAI) as Country Director for Cambodia and Director of Finance and Operations for the Southeast Asia region. In Cambodia, Mike managed programs that provided technical assistance to various departments within the Ministry of Health. Regionally, he provided operational management support to 5 other countries that was primarily focused on scaling up access to Adult and Pediatrics HIV care and treatment. Mike also worked for CHAI in Ethiopia as Deputy Country Director where he helped manage CHAI's largest country office with programs that spanned the health sector. 

Prior to joining CHAI, Mike spent 4 years working with the American Red Cross (ARC) as a Finance Manager for its Biomedical Services unit, and also as the Country Representative for the Maldives Tsunami Program managing operations and programs in Water & Sanitation and Psychosocial Support. He joined ARC in 2006 following a position at the World Bank in Washington DC, where he worked in a Leadership and Organizational Effectiveness group which focused on strengthening overall management capacity in the Bank across the globe. His background is in Financial Management, having also worked for PricewaterhouseCoopers in both the US and Australia. 

Mike has an MBA from INSEAD in France, and an undergraduate degree in both Finance and Computer Applications from the University of Notre Dame in Indiana.Mike lives in Seattle with his wife (Carla-Peruvian) and their three boys (10, 9, 5). Mike loves to travel having visited over 60 countries while being outdoors whether it be camping with his family, doing triathlons or coaching his boys in various sports (soccer, baseball).

 

Stefan Wiktor

WHO, retired

 

Dr. Stefan Wiktor (Seattle WA USA) is a public-health physician with more than twenty-five years’ experience in epidemiologic research and implementation of public-health programs. 

Dr. Wiktor was the founding Team Lead of the WHO’s Global Hepatitis Programme in Geneva, Switzerland, which works with WHO Regional and country officials to promote the implementation of comprehensive viral hepatitis prevention and control programs. 

While working for the U.S. CDC, he conducted research studies of HIV-1 and HIV-2 epidemiology in West Africa and led the implementation of a large-scale HIV/AIDS prevention and treatment program in Tanzania. He is the author of more than 100 peer-reviewed scientific publications. He received his medical degree from Pennsylvania State University School of Medicine, public health degree from Johns Hopkins University and completed his internal medicine training at Georgetown University.